Clinical Trials Results - National Cancer Institute

Skip to content

National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?


	1-800-4-CANCER

	LiveHelp® online chat

	NCI Highlights


	Virtual and Standard Colonoscopy Both Accurate Denosumab May Help Prevent Bone Loss Past Highlights



Results: 1 -2 of 2 Show results per page	View Search Criteria \| Help With Results


Sort By:	Version:	Format:


1.		A Novel Vaccine for the Treatment of MUC1-Expressing Tumor Malignancies

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Approved-not yet active				Over 18				Other				191203-HMO-CTIL NCT00162500

Last Modified: 8/28/2008 First Published: 3/19/2008


2.		Randomized Study of Vaccine Therapy Comprising MUC1 Antigen, HER-2/neu Peptides, and Sargramostim (GM-CSF)and/or CpG Oligodeoxynucleotide in Patients With Previously Treated Stage II or III Adenocarcinoma of the Breast

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	No phase specified				Biomarker/Laboratory analysis, Treatment				Active				18 and over				NCI				MAYO-MC0338 MC0338, NCT00640861

Select All on One Page

| | | | | | | |

A Service of the National Cancer Institute